Study reveals molecular basis for endocrine therapy-resistant breast cancer

[News]

Mitsuyoshi Nakao, Director of the Institute of Molecular Embryology and Genetics in Kumamoto University and Associate Professor Noriko Saitoh revealed that a cluster of defined, non-coding RNAs are mechanistically involved in endocrine therapy resistance in human breast cancer cells. Furthermore, resveratrol, a kind of polyphenol, was found to repress these RNAs and inhibit the proliferative activity of breast cancer cells which had acquired resistance.

More... (http://www.news-medical.net/news/20150527/Study-reveals-molecular-basis-for-endocrine-therapy-resistant-breast-cancer.aspx)